Courtesy www.news18.com
Pune: The Serum Institute of India (SII) is currently developing another vaccine with US drug-maker Novavax. Serum’s CEO Adar Poonawalla said on Saturday he hopes to launch the new vaccine ‘Covovax’ by June.
Covovax has been found to be 89.3 per cent effective in a UK trial.
“Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” Poonawalla tweeted this afternoon.
Poonawalla’s firm is already making Covishield, developed in partnership with the Oxford University and British-Swedish firm AstraZeneca. Covishield and Bharat Biotech’s Covaxin are being used in the first phase of vaccination process in India.
Also Read: Serum Institute Of India Applies For Study Trial Of Novavax Vaccine
Kolkata: A West Bengal secondary board exam (Madhyamik) candidate recently took Artificial Intelligence (AI) to… Read More
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
Delhi/Mumbai: Twin tragedies in Delhi and Mumbai claimed the lives of a pair of 18-month-old… Read More
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
This website uses cookies.
